Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
Open accessAbstract
OBJECTIVE: Adults with diabetes typically take multiple medications for hyperglycemia, diabetes-associated conditions, and other comorbidities. Medication adherence is associated with improved outcomes, including reduced health care costs, hospitalization, and mortality. We conducted a retrospective analysis of a large pharmacy claims database to examine patient, medication, and prescriber factors associated with adherence to antidiabetic medications. RESEARCH DESIGN AND METHODS: We extracted data on a cohort of >200,000 patients who were treated for diabetes with noninsulin medications in the second half of 2010 and had continuous prescription benefits eligibility through 2011. Adherence was defined as a medication possession ratio ≥0.8. We used a modified adherence measure that accounted for switching therapies. Logistic regression analysis was performed to determine factors independently associated with adherence. RESULTS: Sixty-nine percent of patients were adherent. Adherence was independently associated with older age, male sex, higher education, higher income, use of mail order versus retail pharmacies, primary care versus nonendocrinology specialist prescribers, higher daily total pill burden, and lower out-of-pocket costs. Patients who were new to diabetes therapy were significantly less likely to be adherent. CONCLUSIONS: Several demographic, clinical, and potentially modifiable system-level factors were associated with adherence to antidiabetic medications. Patients typically perceived to be healthy (those who are younger, new to diabetes, and on few other medications) may be at risk for nonadherence. For all patients, efforts to reduce out-of-pocket costs and encourage use of mail order pharmacies may result in higher adherence.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Male sex was independently associated with greater treatment adherence (OR 1.14, p = 0.0001).
“In further detail, a study focusing on a variety of factors influencing adherence rates to noninsulin antidiabetic agents indicated that male sex was independently associated with greater treatment adherence (OR 1.14, p = 0.0001) [89].”
From Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care (2022) · cites this paper as [89]
The Results (Patient Factors, Table 2) report that men had greater adjusted odds of adherence than women, with an OR of 1.14. The table gives P < 0.0001, not P = 0.0001 as claimed. (LLM, conf=0.88)
Experimental — accuracy not yet measuredHigh out-of-pocket drug costs are identified as a factor that limits initiation of and adherence to prescribed glucose lowering therapies.
“High out-of-pocket (OOP) drug costs are identified as a factor that limit initiation of and adherence to prescribed glucose lowering therapies.8,9,10,11,12”
From Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease (2023) · cites this paper as [8]
The Conclusions report that higher out-of-pocket costs were associated with lower odds of adherence to noninsulin antidiabetic medications. They also state that the study could not assess primary nonadherence—failure to fill an initial prescription—so it does not establish that costs limit initiation. (LLM, conf=0.90)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,667 · see citing works
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729 · see citing works
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203 · see citing works
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 759 · see citing works
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
Peterson, A. M., Nau, D. P., Cramer, J. A., Benner, J., Gwadry-Sridhar, F. H., & Nichol, M. B. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00139.x · Cited by 638 · see citing works
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903126833 · Cited by 620 · see citing works
Patient Characteristics Associated with Medication Adherence
Rolnick, S. J., Pawloski, P. A., Hedblom, B. D., Asche, S. E., & Bruzek, R. J. (2013) · Clinical Medicine & Research · doi:10.3121/cmr.2013.1113 · Cited by 481 · see citing works
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Asche, C., LaFleur, J., & Conner, C. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.019 · Cited by 420 · see citing works
Manteuffel, M., Williams, S., Chen, W., Verbrugge, R. R., Pittman, D. G., & Steinkellner, A. R. (2013) · Journal of Women s Health · doi:10.1089/jwh.2012.3972 · Cited by 410 · see citing works
Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes
Pladevall, M., Williams, L. K., Potts, L. A., Divine, G., Xi, H., & Lafata, J. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2800 · Cited by 404 · see citing works
Suboptimal statin adherence and discontinuation in primary and secondary prevention populations
Ellis, J. J., Erickson, S. R., Stevenson, J. G., Bernstein, S. J., Stiles, R. A., & Fendrick, A. M. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30516.x · Cited by 318 · see citing works
Chen, C., Tseng, C., & Cheng, S. (2012) · Medical Care · doi:10.1097/mlr.0b013e31827da5b9 · Cited by 183 · see citing works
Untangling the relationship between medication adherence and post–myocardial infarction outcomes
Choudhry, N. K., Glynn, R. J., Avorn, J., Lee, J. L.-Y., Brennan, T. A., Reisman, L., Toscano, M., Levin, R., Matlin, O. S., Antman, E. M., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.09.014 · Cited by 179 · see citing works
Self-citationHo, P. M., Magid, D. J., Masoudi, F. A., McClure, D. L., & Rumsfeld, J. S. (2006) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-6-48 · Cited by 157 · see citing works
Predictors of medication adherence in patients with type 2 diabetes mellitus
Curkendall, S. M., Thomas, N., Bell, K. F., Juneau, P. L., & Weiss, A. J. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.821056 · Cited by 149 · see citing works
The Epidemiology of Prescriptions Abandoned at the Pharmacy
Shrank, W. H., Choudhry, N. K., Fischer, M. A., Avorn, J., Powell, M., Schneeweiß, S., Liberman, J. N., Dollear, T. J., Brennan, T. A., & Brookhart, M. A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-10-201011160-00005 · Cited by 112 · see citing works
Tseng, C., Tierney, E. F., Gerzoff, R. B., Dudley, R. A., Waitzfelder, B. E., Ackermann, R. T., Karter, A. J., Piette, J. D., Crosson, J. C., Ngo‐Metzger, Q., et al. (2008) · Diabetes Care · doi:10.2337/dc07-1341 · Cited by 100 · see citing works
Hong, J. S., & Kang, H. C. (2011) · Medical Care · doi:10.1097/mlr.0b013e31820292d1 · Cited by 95 · see citing works
Breitscheidel, L., Stamenitis, S., Dippel, F. W., & Schöffski, O. (2009) · Journal of Medical Economics · doi:10.3111/13696990903479199 · Cited by 90 · see citing works
Mail-order pharmacy use and adherence to diabetes-related medications.
Duru, O. K., Schmittdiel, J. A., Dyer, W. T., Parker, M. M., Uratsu, C. S., Chan, J., & Karter, A. J. (2010) · PubMed · Cited by 87 · see citing works
Self-citationRodríguez, F., Cannon, C. P., Steg, P. G., Kumbhani, D. J., Goto, S., Smith, S. C., Eagle, K. A., Ohman, E. M., Umez-Eronini, A. A., Hoffman, E., et al. (2013) · Clinical Cardiology · doi:10.1002/clc.22217 · Cited by 82 · see citing works
Hansen, R. A., Farley, J. F., Droege, M., & Maciejewski, M. L. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.011 · Cited by 68 · see citing works
Difficulty adhering to antidiabetic treatment: Factors associated with persistence and compliance
Guénette, L., Moisan, J., Breton, M. ‐., Sirois, C., & Grégoire, J. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.12.005 · Cited by 61 · see citing works
Refill adherence and polypharmacy among patients with type 2 diabetes in general practice
van Bruggen, R., Gorter, K. J., Stolk, R. P., Zuithoff, N. P. A., Klungel, O. H., & Rutten, G. E. H. M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1810 · Cited by 61 · see citing works
Schmittdiel, J. A., Karter, A. J., Dyer, W., Parker, M. M., Uratsu, C. S., Chan, J., & Duru, O. K. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1805-7 · Cited by 55 · see citing works
Self-citationTaira, D. A., Tan, C., Davis, J. W., & Mau, M. L. M. (2013) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12016 · Cited by 48 · see citing works
Iyengar, R. N., Balagere, D. S., Henderson, R. R., LeFrancois, A. L., Rabbitt, R. M., & Frazee, S. G. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.8.851 · Cited by 36 · see citing works
Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes.
Bogner, H. R., de Vries, H. F., O’Donnell, A. J., & Morales, K. H. (2013) · PubMed · Cited by 24 · see citing works
Pharmacy Effect on Adherence to Antidiabetic Medications
Sharma, K. P., & Taylor, T. N. (2012) · Medical Care · doi:10.1097/mlr.0b013e318249d800 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784 · see citing works
“…on large claim databases have identified key demographic factors, such as younger age, lower education level, and lower income, that are associated with poor medication adherence in T2D, 24,32 but it may be of greater importance to identify those critical factors that are potentially modifiable.”
Ohkuma, T., Peters, S. A. E., & Woodward, M. (2018) · Diabetologia · doi:10.1007/s00125-018-4664-5 · Cited by 188 · see citing works
Xie, Z., Liu, K., Or, C., Chen, J., Yan, M., & Wang, H. (2020) · BMC Public Health · doi:10.1186/s12889-020-09274-4 · Cited by 184 · see citing works
Cheen, M. H. H., Tan, Y. Z., Oh, L. F., Wee, H. L., & Thumboo, J. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13350 · Cited by 175 · see citing works
Sex differences in the burden and complications of diabetes
Peters, S. A. E., & Woodward, M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1005-5 · Cited by 172 · see citing works
Rentzeperi, E., Pegiou, S., Koufakis, T., Grammatiki, M., & Kotsa, K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030454 · Cited by 140 · see citing works
Nelson, L. A., Wallston, K. A., Kripalani, S. B., LeStourgeon, L. M., Williamson, S., & Mayberry, L. S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.046 · Cited by 126 · see citing works
Patel, S., Huang, M., & Miliara, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176034 · Cited by 115 · see citing works
Alatorre, C., Fernández Landó, L., Yu, M., Brown, K., Montejano, L., Juneau, P., Mody, R., & Swindle, R. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12902 · Cited by 111 · see citing works
Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health
Venditti, V., Bleve, E., Morano, S., & Filardi, T. (2023) · Metabolites · doi:10.3390/metabo13101087 · Cited by 110 · see citing works
Raparelli, V., Elharram, M., Moura, C. S., Abrahamowicz, M., Bernatsky, S., Behlouli, H., & Pilote, L. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.012940 · Cited by 106 · see citing works
Farmer, A. A., Rodgers, L. R., Lonergan, M. E., Shields, B. M., Weedon, M. N., Donnelly, L. A., Holman, R. R., Pearson, E. R., & Hattersley, A. T. (2015) · Diabetes Care · doi:10.2337/dc15-1194 · Cited by 106 · see citing works
Waari, G., Mutai, J. K., & Gikunju, J. K. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.29.82.12639 · Cited by 104 · see citing works
Marinho, F. D. S., Moram, C. B. D. M., Rodrigues, P. C., Leite, N. C., Salles, G. F., & Cardoso, C. R. L. (2018) · Journal of Diabetes Research · doi:10.1155/2018/8970196 · Cited by 102 · see citing works
Alqarni, A. M., Alrahbeni, T. M. A., AlQarni, A. M., & Qarni, H. M. A. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s176355 · Cited by 101 · see citing works
Psychosocial Determinants of Treatment Adherence in Patients with Type 2 Diabetes – A Review
Świątoniowska-Lonc, N., Tański, W., Polański, J., Jankowska‐Polańska, B., & Mazur, G. J. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s308322 · Cited by 99 · see citing works
Tarumi, S., Takeuchi, W., Chalkidis, G., Rodriguez-Loya, S., Kuwata, J., Flynn, M., Turner, K. M., Sakaguchi, F. H., Weir, C., Kramer, H., et al. (2021) · Methods of Information in Medicine · doi:10.1055/s-0041-1728757 · Cited by 84 · see citing works
Nelson, L. A., Coston, T. D., Cherrington, A., & Osborn, C. Y. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0755-1 · Cited by 83 · see citing works
Karter, A. J., Parker, M. M., Solomon, M. D., Lyles, C. R., Adams, A. S., Moffet, H. H., & Reed, M. (2017) · Health Services Research · doi:10.1111/1475-6773.12700 · Cited by 80 · see citing works
Luo, J., Feldman, R., Callaway Kim, K., Rothenberger, S., Korytkowski, M., Hernandez, I., & Gellad, W. F. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.17886 · Cited by 75 · see citing works
Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease
Inzucchi, S. E., Viscoli, C. M., Young, L. H., Furie, K. L., Gorman, M., Lovejoy, A. M., Dagogo-Jack, S. E., Ismail‐Beigi, F., Korytkowski, M. T., Pratley, R. E., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0798 · Cited by 75 · see citing works
Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73 · see citing works
Menditto, E., Cahir, C., Aza‐Pascual‐Salcedo, M., Bruzzese, D., Poblador‐Plou, B., Malo, S., Costa, E. M., González‐Rubio, F., Miguel, A. G., Orlando, V., et al. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s164819 · Cited by 73 · see citing works
Clemens, K. K., Woodward, M., Neal, B., & Zinman, B. (2020) · Diabetes Care · doi:10.2337/dc19-2257 · Cited by 70 · see citing works
Mattioli, A. V., Sciomer, S., Moscucci, F., Maiello, M. R., Cugusi, L., Gallina, S., Dei, A., Lombardi, C., Pengo, M. F., Parati, G., et al. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000831 · Cited by 67 · see citing works
Giorgino, F., Penfornis, A., Pechtner, V., Gentilella, R., & Corcos, A. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s151736 · Cited by 66 · see citing works
Sheu, W. H., Gantz, I., Chen, M., Suryawanshi, S., Mirza, A., Goldstein, B. J., Kaufman, K. D., & Engel, S. S. (2015) · Diabetes Care · doi:10.2337/dc15-0109 · Cited by 62 · see citing works
Jaam, M., Ibrahim, M. I. M., Kheir, N., & Awaisu, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.015 · Cited by 62 · see citing works
Jaam, M. J., Hadi, M. A., Kheir, N. M., Ibrahim, M. I. M., Diab, M., Abdulla, S. A. A., & Awaisu, A. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s174652 · Cited by 61 · see citing works
Nelson, L. A., Mayberry, L. S., Wallston, K. A., Kripalani, S. B., Bergner, E. M., & Osborn, C. Y. (2016) · JMIR Human Factors · doi:10.2196/humanfactors.6029 · Cited by 61 · see citing works
Malo, S., Aguilar‐Palacio, I., Feja, C., Lallana, M. J., Rabanaque, M. J., Armesto-Gómez, J., & Menditto, E. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1321534 · Cited by 60 · see citing works
Hedna, K., Hakkarainen, K. M., Gyllensten, H., Jönsson, A. K., Sundell, K. A., Petzold, M., & Hägg, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137451 · Cited by 58 · see citing works
Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment
Beran, D., Ewen, M. A., Lipska, K. J., Hirsch, I. B., & Yudkin, J. S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1019-z · Cited by 54 · see citing works
Cersosimo, E., Johnson, E. L., Chovanes, C., & Skolnik, N. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13108 · Cited by 52 · see citing works
Fayed, A. A., Alradini, F. A., Alzuhairi, R., Aljuhani, A. E., Alrashid, H. R., Alwazae, M., & Alghamdi, N. R. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.12.004 · Cited by 52 · see citing works
Diabetes and the Female Disadvantage
Woodward, M., Peters, S. A. E., & Huxley, R. (2015) · Women s Health · doi:10.2217/whe.15.67 · Cited by 51 · see citing works
Teaching Motivational Interviewing to Medical Students: A Systematic Review
Kaltman, S. I., & Tankersley, A. P. (2019) · Academic Medicine · doi:10.1097/acm.0000000000003011 · Cited by 51 · see citing works
Huang, Y., Pecanac, K. E., & Shiyanbola, O. O. (2020) · Qualitative Health Research · doi:10.1177/1049732320945296 · Cited by 51 · see citing works
Mody, R., Grabner, M., Yu, M. B., Turner, R., Kwan, A. Y. M., York, W., & Landó, L. F. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1421146 · Cited by 50 · see citing works
Moustafa, H. A. M., Wakeel, L. M. E., Halawa, M. R., Sabri, N. A., El-Bahy, A. A. Z., & Singab, A. N. B. (2019) · Endocrine · doi:10.1007/s12020-019-01963-4 · Cited by 50 · see citing works
Rahman, M., Nakamura, K., Hasan, S. M. M., Seino, K., & Mostofa, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-63253-8 · Cited by 50 · see citing works
Studer, C. M., Linder, M., & Pazzagli, L. (2023) · Journal of Health Population and Nutrition · doi:10.1186/s41043-023-00459-2 · Cited by 49 · see citing works
Fernández, E. V., McDaniel, J. A., & Carroll, N. V. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.11.1247 · Cited by 49 · see citing works
Remission of type 2 diabetes: always more questions, but enough answers for action
Rothberg, A. E., Lean, M. E. J., & Laferrère, B. (2024) · Diabetologia · doi:10.1007/s00125-023-06069-1 · Cited by 47 · see citing works
Koyanagi, K., Kubota, T., Kobayashi, D., Kihara, T., Yoshida, T., Miisho, T., Miura, T., Sakamoto, Y., Takaki, J., Seo, T., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00212 · Cited by 47 · see citing works
Sex and Gender Bias as a Mechanistic Determinant of Cardiovascular Disease Outcomes
Kim, I., Field, T. S., Wan, D., Humphries, K. H., & Sedlak, T. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.09.009 · Cited by 46 · see citing works
Jaam, M. J., Ibrahim, M. I. M., Kheir, N. M., Hadi, M. A., Diab, M., & Awaisu, A. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.11.001 · Cited by 44 · see citing works
Huber, C. A., & Reich, O. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s115425 · Cited by 42 · see citing works
Individual factors increasing complexity of drug treatment—a narrative review
Schmidt, S. J., Wurmbach, V. S., Lampert, A., Bernard, S., Haefeli, W., Seidling, H. M., Thürmann, P., & HIOPP-6 Consortium (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02818-7 · Cited by 39 · see citing works
Trief, P. M., Kalichman, S. C., Wang, D., Drews, K. L., Anderson, B. J., Bulger, J., & Weinstock, R. S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109216 · Cited by 42 · see citing works
Wilke, T., Mueller, S., Groth, A., Berg, B., Fuchs, A., Sikirica, M., Logie, J., Martin, A., & Maywald, U. (2016) · Diabetes Therapy · doi:10.1007/s13300-015-0149-4 · Cited by 41 · see citing works
Lassen, M. C. H., Johansen, N. D., Modin, D., Catarig, A., Vistisen, B. K., Amadid, H., Zimmermann, E., Gislason, G., & Biering‐Sørensen, T. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15872 · Cited by 40 · see citing works
Okamoto, A., Yokokawa, H., Nagamine, T., Fukuda, H., Hisaoka, T., & Naito, T. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00899-9 · Cited by 36 · see citing works
Cai, J. X., Divino, V. M., & Burudpakdee, C. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1320277 · Cited by 35 · see citing works
Boonpattharatthiti, K., Saensook, T., Neelapaijit, N., Sakunrag, I., Krass, I., & Dhippayom, T. (2023) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2023.11.009 · Cited by 34 · see citing works
Gantz, I., Okamoto, T., Ito, Y., Okuyama, K., O’Neill, E. A., Kaufman, K. D., Engel, S. S., Lai, E., & and the Omarigliptin Study 020 Group (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12988 · Cited by 34 · see citing works
Huang, Y., Shiyanbola, O. O., Chan, H., & Smith, P. D. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1749499 · Cited by 34 · see citing works
Delevry, D., Ho, A., & Le, Q. A. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13109 · Cited by 34 · see citing works
Bailey, T. S., Wu, J., Zhou, F. L., Gupta, R. A., Menon, A. A., Berhanu, P., Westerbacka, J., Vleet, J. V., & Blonde, L. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13818 · Cited by 33 · see citing works
Jaam, M., Awaisu, A., Mohamed Ibrahim, M. I., & Kheir, N. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2017.05.003 · Cited by 32 · see citing works
Alsaidan, A. A., Alotaibi, S., Thirunavukkarasu, A., ALruwaili, B. F., Alharbi, R. H., Arnous, M. M., Alsaidan, O. A., Alduraywish, A. S., & Alwushayh, Y. A. (2023) · Medicina · doi:10.3390/medicina59050989 · Cited by 32 · see citing works
Qin, L., Chen, S., Flood, E. M., Shaunik, A., Romero, B., de la Cruz, M., Alvarez, C., & Grandy, S. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0237-8 · Cited by 32 · see citing works
Katsaridis, S., Grammatikopoulou, M. G., Gkiouras, K., Tzimos, C., Papageorgiou, S. Τ., Markaki, A. G., Exiara, T., Goulis, D. G., & Papamitsou, T. (2020) · Nutrients · doi:10.3390/nu12113516 · Cited by 32 · see citing works
mHealth Intervention Elements and User Characteristics Determine Utility: A Mixed-Methods Analysis
Nelson, L. A., Mulvaney, S. A., Johnson, K. B., & Osborn, C. Y. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0294 · Cited by 32 · see citing works
Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol
McGovern, A. P., Tippu, Z., Hinton, W., Munro, N. M., Whyte, M., & de Lusignan, S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010469 · Cited by 31 · see citing works
Ishii, H., Shin, H., Tosaki, T., Haga, T., Nakajima, Y., Shiraiwa, T., Watanabe, N., Koizumi, M., Nakajima, H., Okada, S., et al. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0414-4 · Cited by 31 · see citing works
Antol, D. D., Casebeer, A. W., Khoury, R. R., Michael, T., Renda, A. M., Hopson, S. D., Parikh, A. R., Stein, A., Costantino, M. E., Stemkowski, S., et al. (2018) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-018-0057-2 · Cited by 31 · see citing works
Owolabi, E. O., Goon, D. T., & Ajayi, A. I. (2020) · Medicine · doi:10.1097/md.0000000000018953 · Cited by 31 · see citing works
Importance of medication adherence in treatment needed diabetic retinopathy
Kao, C.-C., Hsieh, H., Lee, D. Y., Hsieh, K., & Sheu, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-98488-6 · Cited by 31 · see citing works
Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes
Ekenberg, M., Qvarnström, M., Sundström, A., Martinell, M., & Wettermark, B. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03571-8 · Cited by 30 · see citing works
Alfian, S. D., Annisa, N., Fajriansyah, F., Perwitasari, D. A., Abdulah, R., Hak, E., & Denig, P. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-05809-y · Cited by 30 · see citing works
Huang, Y., & Shiyanbola, O. O. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.745749 · Cited by 30 · see citing works
Mayberry, L. S., Mulvaney, S. A., Johnson, K. B., & Osborn, C. Y. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816668374 · Cited by 29 · see citing works
Bruemmer, D., & Nissen, S. E. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000199 · Cited by 29 · see citing works
Pourhabibi, N., Mohebbi, B., Sadeghi, R., Shakibazadeh, E., Sanjari, M., Tol, A., & Yaseri, M. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.976888 · Cited by 29 · see citing works
Nelson, L. A., Mulvaney, S. A., Gebretsadik, T. S., Johnson, K. B., & Osborn, C. Y. (2016) · Journal of Behavioral Medicine · doi:10.1007/s10865-016-9774-2 · Cited by 29 · see citing works
Sebők, J., Édel, Z., Váncsa, S., Farkas, N., Kiss, S., Erőss, B. M., Török, Z., Balogh, G. E., Balogi, Z., Nagy, R., et al. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.2003445 · Cited by 28 · see citing works
Mellergård, E., Johnsson, P., & Eek, F. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00585-6 · Cited by 28 · see citing works
Al‐Noumani, H., Alharrasi, M., José, J., Al‐Naamani, Z., & Panchatcharam, S. M. (2021) · Clinical Nursing Research · doi:10.1177/10547738211033754 · Cited by 27 · see citing works
Ayoub, D., Mroueh, L., El-Hajj, M., Awada, S., Rachidi, S., Zein, S., & Al‐Hajje, A. (2019) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12558 · Cited by 26 · see citing works
Vluggen, S., Hoving, C., Schaper, N. C., & de Vries, H. (2019) · Psychology and Health · doi:10.1080/08870446.2019.1672873 · Cited by 26 · see citing works
Morieri, M. L., Avogaro, A., & Fadini, G. P. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s216054 · Cited by 26 · see citing works
Gautier, J., Boîtard, C., Michiels, Y., Raymond, G., Vergez, G., & Guedon, G. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2021.02.022 · Cited by 26 · see citing works
Chambela, M. D. C., Mediano, M. F. F., Carneiro, F. M., Ferreira, R. R., Waghabi, M. C., Mendes, V. G., Oliveira, L. D. S., de Holanda, M. T., de Sousa, A. S., da Costa, A. R., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14152 · Cited by 26 · see citing works
Hunt, K. J., Davis, M. L., Pearce, J. L., Bian, J., Guagliardo, M. F., Moy, E. M., Axon, R. N., & Neelon, B. (2020) · Diabetes Care · doi:10.2337/dc20-0514 · Cited by 26 · see citing works
Jimenez, K., Vargas, C., García, K. L. B., Guzman, H., Angulo, M., & Billimek, J. (2016) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716675740 · Cited by 25 · see citing works
Mahdavi, M., Vissers, J., Elkhuizen, S., van Dijk, M., Vanhala, A., Karampli, E., Faubel, R., Forte, P. G., Coroian, E., & van de Klundert, J. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192599 · Cited by 25 · see citing works
Chakranon, P., Lai, Y. K., Tang, Y. W., Choudhary, P., Khunti, K., & Lee, S. W. H. (2019) · Diabetic Medicine · doi:10.1111/dme.14156 · Cited by 25 · see citing works
Determinants of medication adherence in patients with diabetes, hypertension, and hyperlipidemia
Chantzaras, A. E., & Yfantopoulos, J. (2025) · HORMONES · doi:10.1007/s42000-025-00631-9 · Cited by 24 · see citing works
Microbes and medicines: interrelationships between pharmaceuticals and the gut microbiome
Al-Btoosh, S., Donnelly, R. F., & KELLY, S. C. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2604867 · Cited by 24 · see citing works
Boye, K. S., Mody, R., Lage, M. J., Douglas, S. D., & Patel, H. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00838-6 · Cited by 24 · see citing works
Choi, Y. J., & Smaldone, A. M. (2017) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721717747880 · Cited by 24 · see citing works
Asheq, A., Ashames, A., Al-Tabakha, M. M., Hassan, N. A. G. M., & Jairoun, A. A. (2021) · F1000Research · doi:10.12688/f1000research.51729.2 · Cited by 23 · see citing works
Derrick, S. A., Nguyen, S. T., Marthens, J. R., Dambacher, L., Sikalidis, A. K., & Reaves, S. K. (2023) · Medicina · doi:10.3390/medicina59101882 · Cited by 23 · see citing works
Azar, K., Mirzaei, A., Babapour, A.-R., & Fathnezhad‐Kazemi, A. (2024) · SAGE Open Medicine · doi:10.1177/20503121231221446 · Cited by 22 · see citing works
HIGHTON, P. J., Funnell, M. P., Gupta, P., Zaccardi, F., Lim, L., Seidu, S., & Khunti, K. (2025) · Diabetologia · doi:10.1007/s00125-025-06617-x · Cited by 22 · see citing works
Benrazavy, L., & Khalooei, A. (2019) · Shiraz E-Medical Journal · doi:10.5812/semj.84746 · Cited by 22 · see citing works
Ito, H., Ando, S., Tsugami, E., Araki, R., Kusano, E., Matsumoto, S., Uemura, K., Nishio, S., Antoku, S., Yamasaki, T., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.025 · Cited by 22 · see citing works
Maev, I. V., Samsonov, A. A., Palgova, L. K., Pavlov, C. S., Shirokova, E. N., & Starostin, K. M. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000307 · Cited by 22 · see citing works
Adherence to metformin monotherapy in people with type 2 diabetes mellitus in New Zealand
Horsburgh, S., Barson, D. J., Zeng, J., SHARPLES, K. J., & Parkin, L. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107902 · Cited by 22 · see citing works
- Authors
- Kirkman, M. S., Rowan-Martin, M. T., Levin, R., Fonseca, V. A., Schmittdiel, J. A., Herman, W. H., & Aubert, R. E.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- American Diabetes Association (US)
- Express Scripts, Franklin Lakes, NJ
- Tulane University (US)
- Kaiser Permanente (US)
- University of Michigan (US)
- Research and Evaluation Analytics, LLC, Ringwood, NJ
- Corresponding author
- Kirkman, M. Sue
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-01-08
- Volume
- 38
- Issue
- 4
- Pages
- 604-609
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC4370331
- OpenAlex
- W2050153005
- Cited by
- 388
- References
- 29
- Citations by year
- 2026: 20 · 2025: 34 · 2024: 37 · 2023: 43 · 2022: 25 · 2021: 54 · 2020: 35 · 2019: 39 · 2018: 28 · 2017: 27 · 2016: 31 · 2015: 15
- FWCI
- 39.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi
- Novo Nordisk
- Amylin Pharmaceuticals
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- medication adherence, antidiabetic drugs, diabetes mellitus, medication possession ratio, predictors of adherence, medication burden, out-of-pocket costs, mail-order pharmacy, prescriber specialty, patient demographics, new-onset diabetes
- MeSH terms
- Assessment of Medication Adherence, Adult, Aged, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Insurance Claim Review, Male, Middle Aged, Pharmacies, Retrospective Studies, Epidemiologic Factors, Databases, Factual, Drug Monitoring, Health Care Costs, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review